biotech news today obesity drugs glp-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Could GLP-1s eventually be replaced?

Learn more: Leqembi (lecanemab-irmb) is an amyloid beta-directed antibody indicated for the treatment of adult patients with Alzheimer's disease

SAMe (S-adenosylmethionine), the active methyl donor produced from methionine, takes 1014 days to reach steady-state tissue levels with weekly dosing

The Lab Analysis: The lab will likely use a method called Liquid Chromatography with tandem Mass Spectrometry (LC/MS-MS)

The push is for patients who want EXTRA glutathione on top of whats in their package, or who want glutathione alone without a full IV session.

Full trial results and Research Summary: nej.md/4ngEZ36 In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes

Brooklyn, N.Y